Clinical Trials › NCT04035005
Active, Not RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Sponsored by Hoffmann-La Roche
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 1013
Target enrollment
5
U.S. states
Aug 2019
Start date
Jan 2028
Expected completion
Interventions / Treatments
OcrelizumabPlacebo
Conditions studied
Multiple Sclerosis, Primary Progressive
Where this trial is running (8 sites)
Florida3 sites
Clearwater · Orlando · Vero Beach
Ohio2 sites
Columbus · Westerville
District of Columbia1 site
Washington D.C.
Kansas1 site
Kansas City
Pennsylvania1 site
Philadelphia
Participating MS centers on MS Buddy (3)
Vero Beach Neurology and Research Institute
Vero Beach, FL
Vero Beach, FL
Georgetown Multiple Sclerosis and Neuroimmunology Center
Washington, DC
Washington, DC
MS centers in Florida
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Florida centersMore Phase 3 trials
Browse all Phase 3 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
